Sirios Capital Management’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$28.1M Buy
355,019
+851
+0.2% +$72.3K 3.41% 6
2026
Q1
$30.5M Buy
354,168
+795
+0.2% +$71.4K 3.7% 5
2025
Q4
$30.9M Sell
353,373
-161,405
-31% -$12.3M 3.84% 4
2025
Q3
$29.5M Sell
514,778
-864
-0.2% -$49.8K 3.84% 4
2025
Q2
$30.4M Buy
515,642
+61,043
+13% +$3.94M 4.41% 5
2025
Q1
$33.3M Buy
454,599
+86,436
+23% +$7.14M 5.94% 4
2024
Q4
$30.5M Sell
368,163
-11,026
-3% -$870K 5.47% 4
2024
Q3
$27.1M Sell
379,189
-1,600
-0.4% -$113K 4.8% 5
2024
Q2
$26.1M Sell
380,789
-2,633
-0.7% -$157K 4.54% 4
2024
Q1
$20.6M Buy
383,422
+14,651
+4% +$788K 3.88% 7
2023
Q4
$19.7M Buy
368,771
+150,820
+69% +$7.35M 4.01% 6
2023
Q3
$10.8M Buy
+217,951
New +$12.2M 2.05% 22

Other funds holding GMED

Sirios Capital Management's GMED Position: Q2 2026 in Review

Sirios Capital Management increased its Globus Medical (GMED) stake by 0.24% in Q2 2026, buying an estimated $72.3K and bringing the position to 355,019 shares worth $28.1M. The position accounts for 3.41% of the portfolio, ranked #6.

Sirios Capital Management first reported a position in GMED in Q3 2023 and has held it in 12 quarters since. The position peaked at $33.3M in Q1 2025. 597 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Sirios Capital Management held 355,019 shares of Globus Medical worth $28.1M as of Q2 2026.
  • Sirios Capital Management bought 851 Globus Medical shares in Q2 2026, an estimated $72.3K.
  • Globus Medical made up 3.41% of Sirios Capital Management's portfolio in Q2 2026, its #6 holding.
  • Sirios Capital Management first reported a position in Globus Medical in Q3 2023 and has held it in 12 quarters since.
  • Sirios Capital Management's Globus Medical position peaked at $33.3M in Q1 2025.
  • 597 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Sirios Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.